UA90651C2 - Способ и устройство для поддержания и контролирования качества сна при терапевтическом лечении - Google Patents
Способ и устройство для поддержания и контролирования качества сна при терапевтическом лечении Download PDFInfo
- Publication number
- UA90651C2 UA90651C2 UAA200503278A UA2005003278A UA90651C2 UA 90651 C2 UA90651 C2 UA 90651C2 UA A200503278 A UAA200503278 A UA A200503278A UA 2005003278 A UA2005003278 A UA 2005003278A UA 90651 C2 UA90651 C2 UA 90651C2
- Authority
- UA
- Ukraine
- Prior art keywords
- parameters
- awakening
- patient
- sleep
- occurrence
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims description 119
- 238000012544 monitoring process Methods 0.000 title claims description 25
- 238000011282 treatment Methods 0.000 title abstract description 4
- 230000003860 sleep quality Effects 0.000 title description 10
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 63
- 230000007958 sleep Effects 0.000 claims description 75
- 230000000241 respiratory effect Effects 0.000 claims description 61
- 239000007789 gas Substances 0.000 claims description 50
- 238000004458 analytical method Methods 0.000 claims description 33
- 230000008859 change Effects 0.000 claims description 31
- 238000001514 detection method Methods 0.000 claims description 30
- 101800000628 PDH precursor-related peptide Proteins 0.000 claims description 25
- 208000008784 apnea Diseases 0.000 claims description 20
- 230000036772 blood pressure Effects 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 14
- 230000002739 subcortical effect Effects 0.000 claims description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 11
- 239000001301 oxygen Substances 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 230000001276 controlling effect Effects 0.000 claims description 10
- 230000001054 cortical effect Effects 0.000 claims description 10
- 208000035475 disorder Diseases 0.000 claims description 10
- 230000033001 locomotion Effects 0.000 claims description 10
- 230000000414 obstructive effect Effects 0.000 claims description 10
- 238000005259 measurement Methods 0.000 claims description 8
- 230000035945 sensitivity Effects 0.000 claims description 8
- 208000003417 Central Sleep Apnea Diseases 0.000 claims description 7
- 230000001105 regulatory effect Effects 0.000 claims description 7
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 6
- 230000010355 oscillation Effects 0.000 claims description 6
- 210000002345 respiratory system Anatomy 0.000 claims description 6
- 230000033764 rhythmic process Effects 0.000 claims description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 4
- 230000000737 periodic effect Effects 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 208000001705 Mouth breathing Diseases 0.000 claims 2
- 230000035790 physiological processes and functions Effects 0.000 claims 2
- IAYJZWFYUSNIPN-KFRZSCGFSA-N (2s,3r,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](OC=2C=CC(=CC=2)[N+]([O-])=O)[C@H](O)[C@H]1O IAYJZWFYUSNIPN-KFRZSCGFSA-N 0.000 claims 1
- 206010008501 Cheyne-Stokes respiration Diseases 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 238000012360 testing method Methods 0.000 claims 1
- 230000037007 arousal Effects 0.000 abstract description 9
- 208000019116 sleep disease Diseases 0.000 abstract description 9
- 230000002269 spontaneous effect Effects 0.000 abstract description 4
- 208000020685 sleep-wake disease Diseases 0.000 abstract description 3
- 230000003434 inspiratory effect Effects 0.000 description 34
- 206010021079 Hypopnoea Diseases 0.000 description 31
- 238000009499 grossing Methods 0.000 description 28
- 208000010340 Sleep Deprivation Diseases 0.000 description 24
- 238000011513 continuous positive airway pressure therapy Methods 0.000 description 22
- 238000002560 therapeutic procedure Methods 0.000 description 20
- 238000012545 processing Methods 0.000 description 18
- 206010041235 Snoring Diseases 0.000 description 16
- 230000007423 decrease Effects 0.000 description 12
- 230000001965 increasing effect Effects 0.000 description 12
- 206010062519 Poor quality sleep Diseases 0.000 description 11
- 230000008569 process Effects 0.000 description 10
- 238000004364 calculation method Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 230000009467 reduction Effects 0.000 description 8
- 230000006978 adaptation Effects 0.000 description 6
- 230000003044 adaptive effect Effects 0.000 description 6
- 101001022170 Homo sapiens FYN-binding protein 2 Proteins 0.000 description 5
- 101000990990 Homo sapiens Midkine Proteins 0.000 description 5
- 102100030335 Midkine Human genes 0.000 description 5
- 206010041349 Somnolence Diseases 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000007726 management method Methods 0.000 description 5
- 238000002106 pulse oximetry Methods 0.000 description 5
- 208000023504 respiratory system disease Diseases 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 206010044565 Tremor Diseases 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000001797 obstructive sleep apnea Diseases 0.000 description 4
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 206010028347 Muscle twitching Diseases 0.000 description 3
- 208000032140 Sleepiness Diseases 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000037321 sleepiness Effects 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- WLKSPGHQGFFKGE-UHFFFAOYSA-N 1-chloropropan-2-yl n-(3-chlorophenyl)carbamate Chemical compound ClCC(C)OC(=O)NC1=CC=CC(Cl)=C1 WLKSPGHQGFFKGE-UHFFFAOYSA-N 0.000 description 2
- -1 CPAP Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000567769 Isurus oxyrinchus Species 0.000 description 2
- 208000037656 Respiratory Sounds Diseases 0.000 description 2
- 206010063968 Upper airway resistance syndrome Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 201000002859 sleep apnea Diseases 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 208000003870 Drug Overdose Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 101000963759 Homo sapiens Melanocortin-2 receptor accessory protein Proteins 0.000 description 1
- 206010021133 Hypoventilation Diseases 0.000 description 1
- 102100040147 Melanocortin-2 receptor accessory protein Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100459301 Mus musculus Myl4 gene Proteins 0.000 description 1
- 206010033296 Overdoses Diseases 0.000 description 1
- 101150093941 PORA gene Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 235000008753 Papaver somniferum Nutrition 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 241001282135 Poromitra oscitans Species 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 206010048232 Yawning Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036626 alertness Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000009118 appropriate response Effects 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 230000005792 cardiovascular activity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000020020 complex sleep apnea Diseases 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 231100000725 drug overdose Toxicity 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002565 electrocardiography Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 201000006646 mixed sleep apnea Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- NQBKFULMFQMZBE-UHFFFAOYSA-N n-bz-3-benzanthronylpyrazolanthron Chemical compound C12=CC=CC(C(=O)C=3C4=CC=CC=3)=C2C4=NN1C1=CC=C2C3=C1C1=CC=CC=C1C(=O)C3=CC=C2 NQBKFULMFQMZBE-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000002496 oximetry Methods 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 230000000803 paradoxical effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000004129 prosencephalon Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000008665 sleep physiology Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000003519 ventilatory effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Данное изобретение предусматривает контроль и обработку сигналов физиологических параметров и спонтанных дыхательных событий с целью выявления возникновения пробуждения. Если возникновение пробуждения выявлено, изобретение предусматривает регулирования, которые необходимы в функционировании терапевтической аппаратуры для избежания или сведения к минимуму пробуждений. По одному из вариантов осуществления изобретение включает в себя один или несколько датчиков, определяющих физиологические параметры пациента, контроллер, который контролирует и выявляет пробуждение, исходя из величин физиологически�
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41744502P | 2002-10-09 | 2002-10-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA90651C2 true UA90651C2 (ru) | 2010-05-25 |
Family
ID=35719179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200503278A UA90651C2 (ru) | 2002-10-09 | 2003-09-10 | Способ и устройство для поддержания и контролирования качества сна при терапевтическом лечении |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1713850B (ru) |
| UA (1) | UA90651C2 (ru) |
| ZA (1) | ZA200502982B (ru) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10891356B2 (en) * | 2008-09-24 | 2021-01-12 | Resmed Sensor Technologies Limited | Contactless and minimal-contact monitoring of quality of life parameters for assessment and intervention |
| WO2011007346A1 (en) * | 2009-06-09 | 2011-01-20 | Respinova Ltd. | Device and methods for applying therapeutic protocols to organs of the cardiopulmonary system |
| JP5798553B2 (ja) | 2009-07-16 | 2015-10-21 | レスメド・リミテッドＲｅｓＭｅｄＬｉｍｉｔｅｄ | 睡眠状態の検出 |
| US9272105B2 (en) * | 2010-07-09 | 2016-03-01 | New York University | System and method for diagnosis and treatment of obstructive sleep apnea |
| EP2663353B1 (en) | 2011-01-14 | 2017-08-16 | Koninklijke Philips N.V. | Measuring continuity of therapy associated with a respiratory treatment device |
| DE102012003509B4 (de) | 2012-02-22 | 2020-06-10 | Drägerwerk AG & Co. KGaA | Beatmungssystem |
| EP3639733B1 (en) * | 2012-05-30 | 2022-10-26 | ResMed Sensor Technologies Limited | Apparatus for monitoring cardio-pulmonary health |
| CN105392514B (zh) * | 2013-04-03 | 2018-03-30 | 皇家飞利浦有限公司 | 具有接口管通气的重症监护通气机 |
| CN105792732B (zh) * | 2013-11-22 | 2020-04-21 | 皇家飞利浦有限公司 | 呼吸暂停安全控制 |
| CN103637798B (zh) * | 2013-12-17 | 2016-03-09 | 山东大学齐鲁医院 | 一种麻醉深度监测装置 |
| FR3019468B1 (fr) * | 2014-04-02 | 2024-07-12 | Fisher & Paykel Healthcare Ltd | Apport de ventilation en pression positive variable en fonction de troubles respiratoires et de l'etat eveille |
| CN112998649A (zh) * | 2015-01-06 | 2021-06-22 | 大卫·伯顿 | 移动式可穿戴的监控系统 |
| CN107427230A (zh) * | 2015-02-05 | 2017-12-01 | Mc10股份有限公司 | 用于与环境相互作用的方法和系统 |
| CN104689444B (zh) * | 2015-03-26 | 2018-08-24 | 北京怡和嘉业医疗科技股份有限公司 | 正压通气治疗机的压力调整方法及系统 |
| WO2017083754A1 (en) * | 2015-11-11 | 2017-05-18 | Inspire Medical Systems, Inc. | Cardiac and sleep monitoring |
| CN109310347B (zh) * | 2016-06-08 | 2022-09-20 | 伊塔玛医疗有限公司 | 生理和病理生理睡眠条件的非侵入性检测方法和装置 |
| CN109715063A (zh) * | 2016-07-13 | 2019-05-03 | 埃罗菲特丹麦有限公司 | 用于锻炼和分析受试者呼吸的呼吸装置和系统 |
| CN106039510B (zh) * | 2016-07-29 | 2018-12-25 | 湖南明康中锦医疗科技发展有限公司 | 呼吸机安全控制的方法、呼吸机及云平台 |
| US10636524B2 (en) * | 2016-08-26 | 2020-04-28 | TCL Research America Inc. | Method and system for optimized wake-up strategy via sleeping stage prediction with recurrent neural networks |
| JP6891038B2 (ja) * | 2017-05-15 | 2021-06-18 | オムロン株式会社 | ウエアラブル装置およびプログラム |
| CN107198805A (zh) * | 2017-07-17 | 2017-09-26 | 太仓秦风广告传媒有限公司 | 一种基于自然呼吸的智能雾化治疗设备 |
| TWI728839B (zh) * | 2020-06-12 | 2021-05-21 | 臺北醫學大學 | 居家睡眠監測器、居家睡眠監測系統以及居家睡眠監測及睡眠呼吸事件分類方法 |
| CN113269318B (zh) * | 2021-06-04 | 2023-06-30 | 安谋科技（中国）有限公司 | 电子设备及其神经网络模型运行方法、存储介质 |
| CN114343373B (zh) * | 2022-01-05 | 2024-06-21 | 浙江想能睡眠科技股份有限公司 | 一种智能调节床垫的方法、系统和存储介质 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5522862A (en) * | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
| AUPN627395A0 (en) * | 1995-10-31 | 1995-11-23 | Compumedics Sleep Pty Ltd | Integrated diagnostic and therapeutic device for gas delivery to patient |
| EP1007125B1 (en) * | 1997-05-07 | 2004-09-15 | Compumedics Sleep Pty. Ltd. | Device for controlling gas or drug delivery to patient |
| EP1121951A1 (de) * | 2000-02-01 | 2001-08-08 | Uvo M. Prof. Hölscher Ph. D. | Regelkreis - System zur Therapie eines Patienten |
| DE60136387D1 (de) * | 2000-12-29 | 2008-12-11 | Ares Medical Inc | Risikobewertung von schlafapnoe |
-
2003
- 2003-09-10 UA UAA200503278A patent/UA90651C2/ru unknown
- 2003-10-09 CN CN200380104013.3A patent/CN1713850B/zh not_active Expired - Fee Related
-
2005
- 2005-04-13 ZA ZA200502982A patent/ZA200502982B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1713850B (zh) | 2012-04-18 |
| CN1713850A (zh) | 2005-12-28 |
| ZA200502982B (en) | 2006-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1551286B1 (en) | Apparatus for maintaining and monitoring sleep quality during therapeutic treatments | |
| US8069852B2 (en) | Method and apparatus for maintaining and monitoring sleep quality during therapeutic treatments | |
| US20220273896A1 (en) | Methods and apparatus for assessing sleep quality | |
| UA90651C2 (ru) | Способ и устройство для поддержания и контролирования качества сна при терапевтическом лечении | |
| EP1750581B1 (en) | Multilevel ventilator | |
| JP7393405B2 (ja) | 睡眠呼吸障害のスクリーニング、診断および監視のためのシステムおよび方法 | |
| RU2198689C2 (ru) | Устройство для подачи газа | |
| US20090107501A1 (en) | System and method of monitoring respiratory airflow and oxygen concentration | |
| Narang et al. | Physiological responses and perceived comfort to high-flow nasal cannula therapy in awake adults: effects of flow magnitude and temperature | |
| Galetke et al. | Comparison of manual titration and automatic titration based on forced oscillation technique, flow and snoring in obstructive sleep apnea |